RA Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $7.14M | Hold |
|
|||||
|
2024
Q4 | $11.6M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $30.1M | Hold |
|
|||||
|
2023
Q2 | $45.6M | Hold |
|
|||||
|
2023
Q1 | $35.6M | Hold |
|
|||||
|
2022
Q4 | $69.3M | Hold |
|
|||||
|
2022
Q3 | $69.2M | Hold |
|
|||||
|
2022
Q2 | $61.4M | Buy |
|
|||||
|
2022
Q1 | $31.3M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $39.6M | Sell |
|
|||||
|
2016
Q2 | $48.5M | Hold |
|
|||||
|
2016
Q1 | $49.8M | Buy |
|
|||||
|
2015
Q4 | $69.1M | Buy |
|